Johnson & Johnson Announces European Commission Approval of Ag... - 09 October 2020 00:43

NEW BRUNSWICK, N.J., Oct. 8, 2020 /PRNewswire-AsiaNet/ -- -- Agreement provides option for European Union Member States to secure up to 200 million additional doses for a total of up to 400 million doses Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting o...

  EB Research Partnership and EB Research Foundation Come Togeth... - 09 October 2020 00:00

NEW YORK and MELBOURNE, Australia, Oct. 9, 2020 /PRNewswire-AsiaNet/ -- -- As the leading EB research funders worldwide, the group will combine to leverage EBRP's innovative business model to accelerate treatments and cures EB Research Partnership (EBRP), based in New York, and EB Research Foundation (EBRF) of Au...

  Merck Celebrates Topping-Out Ceremony for New Membrane Product... - 08 October 2020 23:30

DARMSTADT, Germany, Oct. 8, 2020 /PRNewswire-AsiaNet/ -- - Membrane manufacturing facility for aseptic filters will help meet customer demand in the growing biopharmaceutical market - Investment of more than (EUR) 140 million creates approximately 55 new jobs - Construction expected to be complet...

  ZEISS partners with Microsoft for better patient care through ... - 07 October 2020 20:00

OBERKOCHEN, Germany, and REDMOND, Wash., Oct. 7, 2020 /PRNewswire-AsiaNet/ -- Today, ZEISS Group and Microsoft Corp. announced a multi-year strategic partnership to accelerate ZEISS' transformation into a digital services provider that is embracing a cloud-first approach. By standardizing its equipment and processes on Micr...

  Nagase R&D Center Increases Productivity of Rare Amino Acid "E... - 07 October 2020 17:00

TOKYO, Oct. 7, 2020 /Kyodo JBN-AsiaNet/ -- The Nagase R&D Center, the research and development arm of NAGASE & CO., LTD. based in Tokyo, has been developing fermentative production technology for ergothioneine (EGT) (*1) and researching EGT's functions. Using revolutionary biotechnology de...

  Merck Announces Out-Licensing Agreement for Phase II-ready Ant... - 06 October 2020 23:33

DARMSTADT, Germany, Oct.. 6, 2020 /PRNewswire-AsiaNet/-- Not intended for UK and US based media - Merck out-licenses promising clinical-stage program to Novartis - Anti-ADAMTS5 Nanobody® program is Phase II-ready with novel MoA which could protect against cartilage damage and reduce joint pain ...

  Medicom Announces New USA Mask Manufacturing Plant - 06 October 2020 22:00

MONTREAL, Oct. 6, 2020 /PRNewswire-AsiaNet/ -- The Medicom Group ("Medicom"), one of the world's leading manufacturers of surgical and respiratory masks, today announced the expansion of its U.S. mask manufacturing operations. The company will be adding a second factory with triple the square ...

  Mercy Ships Announces the Global Mercy, World's Largest NGO Ho... - 06 October 2020 16:01

GARDEN VALLEY, Texas, Oct. 6, 2020 /PRNewswire-AsiaNet/ -- -- Over 16 million people die each year due to lack of surgical care; Mercy Ships builds a response to this world problem for the future Today, Mercy Ships announced a first look at the construction of the world's largest NGO hospital ship whi...

  Rockefeller virologist Charles M. Rice honored with Nobel Priz... - 06 October 2020 06:06

NEW YORK, Oct. 6, 2020 /PRNewswire-AsiaNet/ -- Charles M. Rice ( https://c212.net/c/link/?t=0&l=en&o=2939845-1&h=2408583115&u=https%3A%2F%2Fwww.rockefeller.edu%2Four-scientists%2Fheads-of-laboratories%2F893-charles-m-rice%2F&a=Charles+M.+Rice ), who studies disease-causing viruses and how the ...

  The Big Heart Foundation (TBHF): Wife of Sharjah Ruler announc... - 06 October 2020 00:23

SHARJAH, UAE, October 5, 2020 /PRNewswire-AsiaNet/-- Following the directives of Her Highness Sheikha Jawaher bint Mohammad Al Qasimi, Wife of His Highness the Ruler of Sharjah, UAE, Chairperson of The Big Heart Foundation (TBHF), and Founder and Royal Patron of the Friends Of Cancer Patients (FOCP)...